Investors Research Corp Kaleido Biosciences, Inc. Transaction History

Investors Research Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$0.05 - $1.7 $5 - $170	-100 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$5.82 - $8.72 $174 - $261	-30 Reduced 23.08%	100 $1,000
Q1 2021 Apr 28, 2021	SELL	$7.2 - $16.82 $180 - $420	-25 Reduced 16.13%	130 $1,000
Q3 2020 Oct 20, 2020	BUY	$5.09 - $11.07 $788 - $1,715	155 New	155 $2,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

Stay updated on Investors Research Corp with notifications on news.